Abstract
This chapter describes a method for the measurement of free gadolinium in nanoparticle samples. Conjugation of a gadolinium-chelate to a nanoparticle allows the particle’s distribution to be imaged via magnetic resonance imaging (MRI). Free (unchelated) gadolinium is a known toxin, being a heavy metal, and may contribute towards total gadolinium concentration. Determining the amount of free gadolinium is therefore an important aspect of the preclinical characterization of gadolinium-chelate MRI imaging agent nanoparticles.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Gouin, S. and Winnik, F.M. (2001) Quantitative Assays of the Amount of Diethylenetriamine-pentaacetic Acid Conjugated to Water-Soluble Polymers Using Isothermal Titration Calori metry and Colorimetry. Bioconjug. Chem. 12, 372–377.
Acknowledgment
This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Clogston, J.D., Patri, A.K. (2011). Detecting and Measuring Free Gadolinium in Nanoparticles for MRI Imaging. In: McNeil, S. (eds) Characterization of Nanoparticles Intended for Drug Delivery. Methods in Molecular Biology, vol 697. Humana Press. https://doi.org/10.1007/978-1-60327-198-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-60327-198-1_10
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-197-4
Online ISBN: 978-1-60327-198-1
eBook Packages: Springer Protocols